January 26, 2012
Zoledronic Acid Controversy in Breast Cancer Continues
A growing body of evidence backs the contention that bisphosphonates can improve survival in breast cancer patients with low estrogen levels. The results of three studies of bisphosphonates in this setting presented at the recent San Antonio Breast Cancer Symposium (SABCS) support the low estrogen hypothesis, whereas interim results of a fourth trial presented there […]
Tags: Breast Cancer, Dr. James Ingle, estrogen levels, oncology, San Antonio Breast Cancer Symposium